Kazunari Murakami

Summary

Affiliation: Oita University
Country: Japan

Publications

  1. ncbi Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis
    Kazunari Murakami
    Department of Gastroenterology, Oita University Faculty of Medicine, 1 1 Idaigaoka, Hasama, Oita 879 5593, Japan
    World J Gastroenterol 12:2713-20. 2006
  2. ncbi Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection
    Kazunari Murakami
    Faculty of Medicine, Department of Gastroenterology, Oita University, Oita, Japan
    J Clin Gastroenterol 42:139-42. 2008
  3. ncbi Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study
    Kazunari Murakami
    Department of Gastroenterology, Faculty of Medicine, Oita University, 1 1 Idaigaoka, Hasama machi, Yufu, Oita, Japan
    Scand J Gastroenterol 46:287-92. 2011
  4. ncbi Helicobacter pylori eradication and associated changes in the gastric mucosa
    Kazunari Murakami
    Department of Gastroenterology, Oita University, Faculty of Medicine, 1 1 Hasama, Oita 879 5593, Japan
    Expert Rev Anti Infect Ther 3:757-64. 2005
  5. ncbi Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
    Kazunari Murakami
    Department of Gastroenterology, Faculty of Medicine, Oita University, 1 1 Idaigaoka Hasama, Oita 879 5593, Japan
    Helicobacter 11:436-40. 2006
  6. ncbi Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial
    Kazunari Murakami
    Second Department of Internal Medicine, Oita University, 1 1 Hasama, Oita, Japan
    J Gastroenterol Hepatol 21:1048-53. 2006
  7. ncbi Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection
    Kazunari Murakami
    Department of General Medicine, Faculty of Medicine, Oita University and Arita Gastrointestinal Disease Hospital, Oita, Japan
    J Gastroenterol Hepatol 21:262-7. 2006
  8. ncbi Genotyping of the cagA gene of Helicobacter pylori on immunohistochemistry with East Asian CagA-specific antibody
    Ryoko Kanada
    Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan
    Pathol Int 58:218-25. 2008
  9. ncbi Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: an immunohistochemical study of East-Asian-type CagA
    Takashi Abe
    Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan
    J Gastroenterol Hepatol 26:688-93. 2011
  10. ncbi Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice
    Koichiro Watanabe
    Department of Infectious Diseases, Faculty of Medicine, Oita University, Oita, Japan
    Antimicrob Agents Chemother 48:4582-8. 2004

Collaborators

Detail Information

Publications75

  1. ncbi Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis
    Kazunari Murakami
    Department of Gastroenterology, Oita University Faculty of Medicine, 1 1 Idaigaoka, Hasama, Oita 879 5593, Japan
    World J Gastroenterol 12:2713-20. 2006
    ..Further progress in research into H pylori eradication as a viable prophylaxis of gastric cancer, as well as into the mechanisms of gastric carcinogenesis, is to be eagerly awaited for the current year and beyond...
  2. ncbi Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection
    Kazunari Murakami
    Faculty of Medicine, Department of Gastroenterology, Oita University, Oita, Japan
    J Clin Gastroenterol 42:139-42. 2008
    ....
  3. ncbi Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study
    Kazunari Murakami
    Department of Gastroenterology, Faculty of Medicine, Oita University, 1 1 Idaigaoka, Hasama machi, Yufu, Oita, Japan
    Scand J Gastroenterol 46:287-92. 2011
    ..pylori eradication therapy. We therefore compared the efficacy of irsogladine with famotidine as appropriate treatments for ulcers after eradication therapy...
  4. ncbi Helicobacter pylori eradication and associated changes in the gastric mucosa
    Kazunari Murakami
    Department of Gastroenterology, Oita University, Faculty of Medicine, 1 1 Hasama, Oita 879 5593, Japan
    Expert Rev Anti Infect Ther 3:757-64. 2005
    ..pylori eradication is also required to explore strategies for the prevention of gastric cancer with H. pylori eradication...
  5. ncbi Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
    Kazunari Murakami
    Department of Gastroenterology, Faculty of Medicine, Oita University, 1 1 Idaigaoka Hasama, Oita 879 5593, Japan
    Helicobacter 11:436-40. 2006
    ..The authors assessed the efficacy and safety of second-line eradication using the H2-receptor antagonist famotidine as a substitute for proton pump inhibitor...
  6. ncbi Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial
    Kazunari Murakami
    Second Department of Internal Medicine, Oita University, 1 1 Hasama, Oita, Japan
    J Gastroenterol Hepatol 21:1048-53. 2006
    ..This study examined the possible relationship between peptic ulcer recurrence and the presence or absence of maintenance therapy with an H(2)-receptor antagonist performed until evaluation of Helicobacter pylori eradication...
  7. ncbi Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection
    Kazunari Murakami
    Department of General Medicine, Faculty of Medicine, Oita University and Arita Gastrointestinal Disease Hospital, Oita, Japan
    J Gastroenterol Hepatol 21:262-7. 2006
    ..The purpose of the present paper was to measure the in vitro antibacterial activity of minocycline against H. pylori, and study the effectiveness of minocycline-based first- and second-line eradication therapies...
  8. ncbi Genotyping of the cagA gene of Helicobacter pylori on immunohistochemistry with East Asian CagA-specific antibody
    Ryoko Kanada
    Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan
    Pathol Int 58:218-25. 2008
    ..2%) and specific (specificity 72.7%), suggesting that immunohistochemical diagnosis of the cagA genotype is useful for diagnosis of the cagA genotype...
  9. ncbi Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: an immunohistochemical study of East-Asian-type CagA
    Takashi Abe
    Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan
    J Gastroenterol Hepatol 26:688-93. 2011
    ..In this study, the correlations between Helicobacter pylori CagA protein diversity and gastric mucosal condition was investigated using immunohistochemical staining with ?-EAS Ab in Japan...
  10. ncbi Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice
    Koichiro Watanabe
    Department of Infectious Diseases, Faculty of Medicine, Oita University, Oita, Japan
    Antimicrob Agents Chemother 48:4582-8. 2004
    ..Sucralfate delays gastric clearance of CAM and physically captures H. pylori through the creation of an adherent mucus, which leads to bacterial clearance...
  11. ncbi Evaluation of Helicobacter pylori status and endoscopic findings among new outpatients with dyspepsia in Japan
    Seiji Shiota
    Department of General Medicine, Faculty of Medicine, Oita University, 1 1 Idaigaoka, Hasama machi, Yufu, Oita, 879 5593, Japan
    J Gastroenterol 44:930-4. 2009
    ..pylori-positive and-negative, respectively. To establish Japanese guidelines for dyspepsia, we evaluated H. pylori status and endoscopic findings among outpatients with dyspepsia...
  12. ncbi Prevalence of two homologous genes encoding glycosyltransferases of Helicobacter pylori in the United States and Japan
    Miyuki Matsuda
    Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu City, Oita, Japan
    J Gastroenterol Hepatol 26:1451-6. 2011
    ..We examined the prevalence of jhp0562, ?-(1,3)galT, and cagA in the United States (US) and Japanese populations...
  13. ncbi Evaluation of rapid urine test for the detection of Helicobacter pylori infection in the Vietnamese population
    Lam Tung Nguyen
    Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu City, Oita 879 5593, Japan
    Dig Dis Sci 55:89-93. 2010
    ..This study attempted to assess the value of the RAPIRUN test for the diagnosis of Helicobacter pylori infection in the Vietnamese population...
  14. ncbi Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy
    Hisanori Abe
    Arita Gastro-Intestinal Hospital, 1-2-6 Maki, Oita, 870-0924, Japan
    J Gastroenterol 40:563-9. 2005
    ..pylori infection and with a lower degree of inflammatory cellular infiltration...
  15. ncbi Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura
    Ryugo Sato
    Second Department of Internal Medicine, Faculty of Medicine, Oita University, Oita, Japan
    Arch Intern Med 164:1904-7. 2004
    ..We determined the prevalence of H pylori infection in Japanese patients with chronic ITP and the effect of its eradication on platelet count...
  16. ncbi Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial
    Akira Terano
    Department of Gastroenterology, Dokkyo University School of Medicine, Tochigi, Japan
    J Gastroenterol 42:690-3. 2007
    ..We examined the efficacy of rebamipide in gastric ulcer healing following 1 week of eradication therapy in a randomized, double-blind, placebo-controlled trial...
  17. ncbi Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping
    Lam Tung Nguyen
    Department of Molecular Pathology, Faculty of Medicine, Oita University, Yufu City, Oita, Japan
    Clin Vaccine Immunol 16:1687-92. 2009
    ..7%, 97.9%, and 97.1%, respectively. Moreover, anti-EAS Ab was not cross-reactive with noninfected gastric mucosa. In conclusion, immunohistochemistry with anti-EAS Ab appears to be a good method for determination of CagA phenotype...
  18. ncbi Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection
    Kazunari Murakami
    Second Department of Internal Medicine, Oita Medical University, 1-1 Hasama, 879-5593 Oita, Japan
    J Gastroenterol 38:937-41. 2003
    ..In this study, the effects of the anti-ulcer drugs used in Japan on the results of the UBT were determined...
  19. ncbi Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population
    Tomohisa Uchida
    Department of Molecular Pathology, Oita University Faculty of Medicine, Yufu, Japan
    BMC Microbiol 9:175. 2009
    ..The aim of this study was to investigate several genetic factors regarded as virulence or molecular epidemiologic markers in H. pylori isolates from Vietnamese subjects...
  20. ncbi Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis
    Masaaki Kodama
    Department of Gastroenterology, Oita University, Faculty of Medicine, 1 1 Idaigaoka, Hasama machi, Oita Gun, Oita 879 55, Japan
    World J Gastroenterol 11:7063-71. 2005
    ....
  21. ncbi Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura
    Ryugo Sato
    Department of Gastroenterology and General Medicine, Oita University, Idaigaoka, Hasama machi, Yufu, Japan
    J Gastroenterol 46:991-7. 2011
    ..To clarify the pathogenesis of H. pylori-induced ITP and the factors predicting the platelet response to H. pylori eradication therapy, we evaluated the markers of atrophic gastritis in ITP patients...
  22. ncbi Expression of mutant type-p53 products in H pylori-associated chronic gastritis
    Masaaki Kodama
    Department of Gastroenterology, Oita University, Hasama machi, Oita, 879 5593, Japan
    World J Gastroenterol 13:1541-6. 2007
    ..To investigate the mutation of p53 immunohistochemically in non-tumorous gastric mucosa with H pylori infection before and after H pylori eradication therapy...
  23. ncbi Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan
    Tadayoshi Okimoto
    Second Department of Internal Medicine, and Department of General Medicine, Oita Medical University, Oita, Japan
    Helicobacter 8:186-91. 2003
    ..CONCLUSION: Reinfection of H. pylori was not as rare at 6 months after eradication as reported previously, and up to 6 years after eradication, the annual reinfection rate is 2.0% per patient year in Japan...
  24. ncbi Aspirin-induced small bowel injuries and the preventive effect of rebamipide
    Kazuhiro Mizukami
    Department of General Medicine and Gastroenterology, Faculty of Medicine, Oita University, Yufu, Oita 879 5593, Japan
    World J Gastroenterol 17:5117-22. 2011
    ..To evaluate the influence of taking low-dose aspirin for 4 wk on small intestinal complications and to examine the preventive effect of rebamipide...
  25. ncbi Evaluation of esophageal function in patients with gastroesophageal reflux disease using transnasal endoscopy
    Shigeaki Yasaka
    Department of Gastroenterology, Oita University Faculty of Medicine, Yufu, Oita 879 5593, Japan
    J Gastroenterol Hepatol 24:1677-82. 2009
    ..To investigate the utility of a new method of carrying out esophageal manometry using a narrow gauge manometry catheter via a transnasal endoscope...
  26. ncbi A novel diagnostic monoclonal antibody specific for Helicobacter pylori CagA of East Asian type
    Aiko Yasuda
    Institute of Scientific Research, Faculty of Medicine, Oita University, Oita, Japan
    APMIS 117:893-9. 2009
    ..We also analyzed the localization of the CagA protein in H. pylori-infected gastric mucosa with fluorescence immunohistochemistry, and found that CagA protein expression was up-regulated by adhesion to epithelial cells...
  27. ncbi Analysis of p53 mutations and Helicobacter pylori infection in human and animal models
    Kazunari Murakami
    Second Department of Internal Medicine, Oita Medical University, Japan
    J Gastroenterol 37:1-5. 2002
    ..However, our direct DNA sequencing method showed no p53 mutations in the Mongolian gerbil model at present. Further studies with this model are needed...
  28. ncbi Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population
    Kazunari Murakami
    Department of Gastroenterology, Faculty of Medicine, Oita University, 1 1 Idaigaoka, Hasama, Oita, 879 5593, Japan
    J Gastroenterol 44:40-3. 2009
    ..In Japan, national health insurance does not cover procedures that prevent or lower the risk for NSAID-induced ulcer. When administering NSAID to patients with risk factors, it is desirable to administer antiulcer agents...
  29. ncbi Enterocromaffin-like cell tumor induced by Helicobacter pylori infection in Mongolian gerbils
    Jiro Kagawa
    Department of General Medicine, Oita Medical University, Hasama-machi, Oita, Japan
    Helicobacter 7:390-7. 2002
    ..This model is thought to be useful to study the relationship between hypergastrinemia and gastric carcinoids...
  30. ncbi [Sclerosing cholangitis with autoimmune pancreatitis which resembles cholangiocarcinoma]
    Masaaki Kodama
    Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu
    Nippon Naika Gakkai Zasshi 96:2525-8. 2007
  31. ncbi Helicobacter pylori and gastric carcinoma--from the view point of animal model
    Toshio Fujioka
    Department of General Medicine, Oita Medical University, Oita, Japan
    Keio J Med 51:69-73. 2002
    ..These important results provide a starting point for further studies to clarify the mechanism of gastric carcinogenesis as a result of H. pylori infection and assist the planning of eradication therapy to prevent gastric carcinoma...
  32. ncbi Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization
    Akiko Kuroda
    Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan
    PLoS ONE 6:e22313. 2011
    ....
  33. ncbi [Second-line eradication therapy for H. pylori infection]
    Kazunari Murakami
    Second Department of Internal Medicine, Oita University
    Nippon Rinsho 62:489-94. 2004
    ..pylori, despite its worldwide use as an antimicrobial agent in H. pylori eradication regimens...
  34. ncbi [Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines]
    Masaaki Kodama
    Department of Gastroenterology, Faculty of Medicine, Oita University
    Nihon Rinsho 66:804-10. 2008
    ..Japanese guideline in 2003 does not mention the effect of eradication for prevention of gastric cancer. The H. pylori eradication and new strategy should be desirable for global strategy of gastric cancer prevention...
  35. ncbi Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa
    Masaaki Kodama
    Department of General Medicine, Faculty of Medicine, Oita University, Hasama machi, Oita 879 5593, Japan
    J Gastroenterol Hepatol 20:941-6. 2005
    ..To clarify the role of H. pylori in carcinogenesis, the expression of tumor suppressor p53 and its regulator multiple double minute 2 (MDM2) in gastric mucosa were examined before and after H. pylori eradication...
  36. ncbi Helicobacter pylori virulence and the diversity of gastric cancer in Asia
    Lam Tung Nguyen
    Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita 879 5593, Japan
    J Med Microbiol 57:1445-53. 2008
    ..The possible link between the geographical distribution of cagPAI and cagA variations and gastric cancer diversity in Asia is also discussed...
  37. ncbi The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan
    Seiji Shiota
    Department of General Medicine, Oita University Faculty of Medicine, 1 1 Idaigaoka, Hasama machi, Yufu, Oita 879 5593, Japan
    J Neurol 258:1460-3. 2011
    ..83, respectively). The prevalence of H. pylori infection did not differ between AD patients and controls among Japanese subjects. The high prevalence of H. pylori in controls may contribute to the discrepancy with previous reports...
  38. ncbi [Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy]
    Tadayoshi Okimoto
    Department of Gastroenterology, Faculty of Medicine, Oita University
    Nippon Rinsho 63:435-7. 2005
  39. ncbi Association of Helicobacter pylori dupA With the Failure of Primary Eradication
    Seiji Shiota
    Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, 1 1 Idaigaoka, Hasama machi, Yufu City, Oita 879 5593, Japan
    J Clin Gastroenterol 46:297-301. 2012
    ..To determine whether the presence of dupA Helicobacter pylori (H. pylori) influences the cure rate of primary eradication therapy...
  40. ncbi Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test
    Masaaki Kodama
    Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu City, Oita 879 5593, Japan
    World J Gastroenterol 18:44-8. 2012
    ..To investigate the effects of proton pump inhibitor (PPI) treatment on stool antigen test using the TestMate pylori enzyme immunoassay...
  41. ncbi Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization
    Masahiro Uchida
    Department of Molecular Pathology, Oita University, Oita, Japan
    J Pathol 221:96-105. 2010
    ..Since HGA is believed to have a higher risk of progression to invasive carcinoma than LGA, these data suggest that 8q gain is important for the malignant transformation of gastric adenoma...
  42. ncbi An evaluation of the performance of a novel stick-type kit for rapid detection of Helicobacter pylori antibodies in urine
    Kazunari Murakami
    Department of General Medicine, Faculty of Medicine, Oita University, Oita, Japan
    Clin Lab 57:481-7. 2011
    ..pylori infection. The aim of this study was to evaluate the performance and correlation of this kit with the original kit and the ELISA kit...
  43. ncbi Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective
    Seiji Shiota
    Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, 1 1 Idaigaoka, Hasama machi, Yufu City, Oita 879 5593, Japan
    Expert Rev Gastroenterol Hepatol 4:149-56. 2010
    ..Overall, the most important and dramatic revision is that all infected people are recommended to receive eradication therapy irrespective of the clinical outcomes in the Japanese population...
  44. ncbi Animal models for the study of Helicobacter-induced gastric carcinoma
    Masaaki Kodama
    Department of General Medicine, Oita University, Hasama-machi, Oita 879-5593, Japan
    J Infect Chemother 10:316-25. 2004
    ..These important results provide a starting point for further studies to clarify the mechanism of gastric carcinogenesis as a result of H. pylori infection and assist in the planning of eradication therapy to prevent gastric carcinoma...
  45. ncbi Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects
    Toshio Fujioka
    Department of Gastroenterology and Division of Digestive Endoscopy, Oita University Faculty of Medicine, 1 1 Idaigaoka, Yufu, 879 5593, Japan
    J Gastroenterol 42:3-6. 2007
    ..Finally, areas requiring further clinical research and endeavors, including establishment of second-line eradication therapy, were also proposed in the 2003 Guidelines to point the way for the future...
  46. ncbi Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation
    Masaaki Kodama
    Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan
    Digestion 85:126-30. 2012
    ..To clarify the mechanism by which H. pylori eradication prevents gastric cancer, we monitored atrophy and IM improvement in gastric mucosa over a long period after H. pylori eradication...
  47. ncbi Pancreatic injury successfully treated with endoscopic stenting for major pancreatic duct disruption
    Takashi Abe
    Department of General Medicine and Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan
    Intern Med 48:1889-92. 2009
    ..CT on the 9th hospital day showed acute pancreatic fluid collections, but these had disappeared at the 3 month follow-up CT. The patient has remained asymptomatic at follow-up for 3 years...
  48. ncbi [Acquisition of the drug resistance and Helicobacter pylori gene mutation]
    Tadayoshi Okimoto
    Department of Gastroenterology, Faculty of Medicine, Oita University
    Nihon Rinsho 67:2372-7. 2009
    ..The resistant rates of each antibiotics may increase in future, so we need to observe those changes...
  49. ncbi Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen
    Kazunari Murakami
    Department of Gastroenterology, Faculty of Medicine, Oita University, 1 1 Idaigaoka, Hasama machi, Yuhu, Oita 879 5593, Japan
    J Gastroenterol 46:1120-6. 2011
    ..Helicobacter hepaticus infection might be associated with liver and biliary tract diseases. To investigate its pathogenic role, the properties of anti-H. hepaticus serum antibody in patients with liver and diseases were elucidated...
  50. ncbi Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody
    Tomohisa Uchida
    Department of Molecular Pathology, Oita University, Yufu City, Oita 879 5593, Japan
    Cancer Sci 98:521-8. 2007
    ....
  51. ncbi Intraperitoneal immunization led to T cell hyporesponsiveness to Helicobacter pylori infection in mice
    Koichiro Watanabe
    Department of Microbiology, Oita Medical University, Oita, Japan
    Microbiol Immunol 46:441-7. 2002
    ..pylori-associated gastritis and induced T cell hyporesponsiveness to H. pylori infection, which might be mediated by the early induction of CTLA-4 following challenge...
  52. ncbi Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study
    Tung L Nguyen
    Department of Molecular Pathology, Oita University, Yufu City, Japan
    BMC Gastroenterol 10:114. 2010
    ..The virulence of Vietnamese H. pylori has also not been investigated in detail...
  53. ncbi Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients
    Hiroto Miwa
    Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan
    Helicobacter 9:9-16. 2004
    ..CONCLUSIONS: Curative treatment of H. pylori infection is useful in preventing ulcer recurrence. Gastric ulcer is more likely to relapse than duodenal ulcer. Recurrent ulcer tended to recur at the site of the original ulcers...
  54. ncbi Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene
    Touta Oda
    Second Department of Internal Medicine, Oita Medical University, Hasama-machi, Japan
    Helicobacter 7:143-51. 2002
    ..pylori infection. Searching for p53 gene mutations may be useful for studying the progression of gastric carcinogenesis associated with H. pylori...
  55. ncbi Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition
    Masahiro Asaka
    Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Helicobacter 15:1-20. 2010
    ..pylori and gastric cancer has been demonstrated more clearly. Accordingly, the committee of the Japanese Society for Helicobacter Research has revised the guidelines for diagnosis and treatment of H. pylori infection in Japan...
  56. ncbi [A case of simple ulcer with ulcerative colitis]
    Masami Ono
    Second Department of Internal Medicine, Faculty of Medicine, Oita University
    Nippon Shokakibyo Gakkai Zasshi 102:894-9. 2005
  57. ncbi Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan
    Masahide Watada
    Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Idaigaoka, Hasama machi, Yufu City, Japan
    BMC Gastroenterol 11:141. 2011
    ..Therefore, we aimed to find novel candidate virulence genes that correlate with cagA and examined the association of these genes with clinical outcomes in Colombian and Japanese populations...
  58. ncbi [Characteristics of gastric cancer occurring after Helicobacter pylori eradication]
    Ryugo Sato
    Department of Gastroenterology, Faculty of Medicine, Oita University
    Nippon Rinsho 63:520-5. 2005
  59. ncbi Gastritis associated with Epstein-Barr virus infection
    Akari Hisamatsu
    Department of Gastroenterology, Oita Kouseiren Tsurumi Hospital, Beppu
    Intern Med 49:2101-5. 2010
    ..Her symptoms spontaneously resolved, and follow-up endoscopy revealed improvement and no atypical lymphocytes. To prevent misdiagnosis and unnecessary treatment, the possibility of EBV-associated gastritis should be considered...
  60. ncbi Duodenal gangliocytic paraganglioma treated with endoscopic hemostasis and resection
    Takayuki Nagai
    Department of Gastroenterology, Oita Kouseiren Tsurumi Hospital, Beppu, Japan
    J Gastroenterol 39:277-83. 2004
    ..In Japan, no previous studies have reported using endoscopic hemostasis, to our knowledge. Our patient is the fourth in Japan to be treated by endoscopic resection. We report on our patient, with a review of the literature...
  61. ncbi [Eosinophilic gastroenteritis in the esophagus, stomach, and small intestine in a patient with a choking feeling in the esophagus]
    Yoshinori Hirashima
    Third Department of Internal Medicine, Oita University Faculty of Medicine, Japan
    Nihon Shokakibyo Gakkai Zasshi 104:660-5. 2007
    ..We therefore diagnosed eosinophilic gastroenteritis. Oral prednisolone relieved clinical conditions and the CT image improved. This case was considered valuable, because there have been few reports of eosinophilic esophagitis in Japan...
  62. ncbi [Clarithromycin (CAM)]
    Kazunari Murakami
    Second Department of Internal Medicine, Oita Medical University
    Nippon Rinsho 60:667-70. 2002
  63. ncbi [Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection]
    Ryugo Sato
    Second Department of Internal Medicine, Oita Medical University
    Nippon Rinsho 60:449-51. 2002
  64. ncbi [Drug resistant H. pylori in Japan: general remarks]
    Kazunari Murakami
    Department of Gastroenterology, Oita University Hospital
    Nippon Rinsho 63:198-202. 2005
  65. ncbi [Occurrence of upper gastrointestinal tract disease after Helicobacter pylori eradication]
    Masaaki Kodama
    Department of General Medicine, Oita Medical University
    Nippon Rinsho 60:1639-43. 2002
    ..pylori eradication and increase of esophageal adenocarcinoma. GERD may cause adenocarcinoma development, though long term observations is necessary after H. pylori eradication...
  66. ncbi Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin
    Takahisa Furuta
    Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan
    J Gastroenterol Hepatol 22:1810-5. 2007
    ..Our aim in this study was to develop a polymerase chain reaction (PCR)-based assay that could determine these mutations in a single reaction tube...
  67. ncbi Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005
    Intetsu Kobayashi
    Chemotherapy Division, Mitsubishi Chemical Medience Corporation, Tokyo, Japan
    J Clin Microbiol 45:4006-10. 2007
    ..The development of an effective H. pylori eradication regimen in Japan will require continued resistance surveillance as well as a better understanding of the epidemiology of resistance...
  68. ncbi [Helicobacter pylori infection and stomach cancer]
    Toshio Fujioka
    Nippon Naika Gakkai Zasshi 94:11-5. 2005
  69. ncbi Helicobacter pylori isolated from patients who later failed H. pylori eradication triple therapy readily develop resistance to clarithromycin
    Intetsu Kobayashi
    Chemotherapy Division, Mitsubishi Kagaku Bio Clinical Laboratories, Inc, 3 30 1 Shimura, Itabashi ku, Tokyo 174 8555, Japan
    J Med Microbiol 55:737-40. 2006
    ..These results suggest that patients in the unsuccessful eradication group were infected with strains of H. pylori that readily became resistant to clarithromycin on exposure to the drug...
  70. ncbi [Drug sensitivity test for Helicobacter pylori]
    Kazunari Murakami
    Second Department of Internal Medicine, Oita Medical University
    Nippon Rinsho 60:350-3. 2002
  71. ncbi [Role of Helicobacter pylori in gastritis, gastric ulcer and gastric carcinogenesis]
    Masaaki Kodama
    Department of General Medicine, Oita Medical University
    Nippon Shokakibyo Gakkai Zasshi 99:1303-11. 2002
  72. ncbi [Helicobacter pylori eradication therapy for extragastrodudenal diseases]
    Ryugo Sato
    Second Department of Internal Medicine, Oita Medical University
    Nippon Shokakibyo Gakkai Zasshi 100:1295-301. 2003
  73. ncbi [Culture method for H. pylori]
    Kazunari Murakami
    Second Department of Internal Medicine, Oita Medical University
    Nippon Rinsho 61:84-7. 2003
    ..This method is necessary for the cases in whom strains are needed its sensitivity to antibiotics. Considering of increase of CAM-resistant H. pylori in the future, culture method should be necesary in the diagnosis of H. pylori...
  74. ncbi [Successful bi-weekly paclitaxel treatment of an AFP-producing gastric cancer patient with peritoneal dissemination and multiple liver metastasis]
    Yoshinori Hirashima
    Third Dept. of Internal Medicine, Oita University Hospital
    Gan To Kagaku Ryoho 33:517-9. 2006
    ..Paclitaxel can be expected to show good therapeutic efficacy and improve QOL of a peritonitis carcinomatosa patient with TS-1 resistant advanced gastric cancer...
  75. ncbi Evaluation of the Helicobacter pylori stool antigen (HpSA) assay for diagnosing infection and confirming eradication after treatment
    Masaaki Kodama
    J Gastroenterol 39:1219-20. 2004